Michael D. Vrbanac

Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX.

American Pathology Partners, Inc. operates as a network of pathology laboratories and practices. The firm provides clinical and technical support services in the areas of molecular diagnostics, flow cytometry, renal and pediatric pathology, perinatal and dermatopathology, cytology and immunohistochemistry; academic-caliber pathology services; and diagnostic services. It also provides subspecialty programs in the areas of women's health, urologic and hematopathology, and gastrointestinal and nephropathology; and business support services, including access to growth capital for liquidity and/or growth, senior management support, client services (sales and marketing), information technology, operational know-how, managed care contracting, billing, group purchasing, finance and accounting, human resources, and compliance. The company was founded by Edward D. Dooling Jr, Thanasis Papaioanu, Robert A. Yeager and Martin S. Rash in February 2008 and is headquartered in Brentwood, TN.

Aseko, Inc. develops network-based systems for glycemic management. The company was founded by Richard Lee Grounsell in March 2006 and is headquartered in Greenville, SC.

At Bravo Health, they understand that people with Medicare today are more active in managing their own health care than prior generations. Health care is changing, and more educated consumers are at the forefront of that change. That's why Bravo Health offers a variety of Medicare Advantage and Part D Prescription Drug plans that provide choice, as well as exceptional value. To deliver the best health care value, they develop strong relationships with its health care providers who help patients make the most of their Bravo Health membership. They offer Medicare Advantage Plans in Delaware, Maryland, New Jersey, Pennsylvania, Texas, and Washington, D.C. as well as Part D Prescription Drug Plans in 43 states. Through these plans, Bravo Health serves over 300,000 members in partnership with over 30,000 physicians. In 2007 its name was changed from 'Elder Health' to better reflect the more active and health-conscious lifestyle of today's seniors. The company remains committed to ensuring that Medicare beneficiaries have access to high-quality, cost effective medical care and they encourage caregivers, family, and friends to participate in the health care decision-making process. Founded in 1996, Bravo Health is headquartered in Baltimore, MD.

MedAvante, Inc. provides signal detection solutions in clinical trials of treatments for central nervous system disorders. It offers Virgil investigative study platform for site-based assessments; and MedAvante central ratings for live assessments. The firm also offers scientific risk reduction services. The company was founded by Paul M. Gilbert, Amy Ellis, Peter B. Tilles, Livingston Johnson and Avik Roy in 2002 and is headquartered in Hamilton, NJ.

New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California.

EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA.

Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT.

Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada.

The Mount Sinai Medical Center, Inc. operates charitable teaching hospitals. The non-profit company is based in New York, NY. The CEO of the company is Gino Santorio.

Centers for Medicare & Medicaid Services provides health care services. It offers medical and healthcare services for the people who are above 65 years. The organization also runs State Children's Health Insurance Program which helps states to cover children. Centers for Medicare & Medicaid Services was founded in 1977 and is located in Baltimore, MD

Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ.

National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA.

US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD.

T.R. Winston & Co., Inc. provides investment banking and securities brokerage services. The firm also provides advisory and financial services to healthcare industry. The company is headquartered in Bedminster, NJ.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Aetion, Inc. provides data analytics software solutions. The firm?s Aetion Evidence Platform enables life sciences customers to transform disparate data sets into evidence needed to make critical business decisions; and helps payers determine effective treatments for specific patient populations and measure impact in outcomes and utilization. The company was founded by Jeremy A. Rassen, Sebastian Schneeweiss and Allon Rauer in 2013 and is headquartered in New York, NY.

Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation.

Alison Raffaele Cosmetics, Inc. manufactures cosmetics and facial makeup products. Its products include powder, lipstick, lip gloss and blush, tools, and brushes. The firm was founded by Alison Raffaele Tatem in 2000 and is headquartered in Cliffside Park, NJ.

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.

I-Flow Corp. designs, develops and manufactures ambulatory drug delivery systems. Its products include portable infusion pumps, catheters and pain kits. The company was founded in 1985 and is headquartered in Lake Forest, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.